mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.04 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.091 |
0.05 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.05 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.057 |
0.05 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |